# OnCo record goteborg-2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/goteborg-2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "goteborg-2", "ISRCTN94604465" ;
  schema:name "GÖTEBORG-2 (MRI-based prostate cancer screening)"@en ;
  schema:description "In GÖTEBORG-2, 17,980 men were screened with PSA, then MRI; biopsying only what the MRI showed halved the detection of harmless prostate cancers (0.6% versus 1.2% of men) while the detection of dangerous cancers barely changed (0.9% versus 1.1%). It is the strongest evidence that MRI-first screening cuts overdiagnosis."@en ;
  schema:url <https://onco.cc/trials/goteborg-2/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2209454> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/prostate-screening-psa-mri/>, <https://onco.cc/technologies/mp-mri/> ;
  onco:terms <https://onco.cc/terms/psa/>, <https://onco.cc/terms/overdiagnosis/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-goteborg-2-n-engl-j-med-2022/> .